VentriPoint Diagnostics Ltd

Medical Devices

Prices are adjusted according to historical splits.

VentriPoint Diagnostics Ltd Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$26.66 million
Book Value:
Revenue TTM:
Operating Margin TTM:
Gross Profit TTM:
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

VentriPoint Diagnostics Ltd had its IPO on under the ticker symbol VPTDF.

The company operates in the Healthcare sector and Medical Devices industry. VentriPoint Diagnostics Ltd has a staff strength of 0 employees.

Stock update

Shares of VentriPoint Diagnostics Ltd opened at $0.15 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.14 - $0.17, and closed at $0.17.

This is a -2.35% slip from the previous day's closing price.

A total volume of 118,710 shares were traded at the close of the day’s session.

In the last one week, shares of VentriPoint Diagnostics Ltd have slipped by -10.42%.

VentriPoint Diagnostics Ltd's Key Ratios

VentriPoint Diagnostics Ltd has a market cap of $26.66 million, indicating a price to book ratio of 8.2705 and a price to sales ratio of 897.0447.

In the last 12-months VentriPoint Diagnostics Ltd’s revenue was $51348 with a gross profit of $-6268 and an EBITDA of $-5038146. The EBITDA ratio measures VentriPoint Diagnostics Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, VentriPoint Diagnostics Ltd’s operating margin was -9827.93% while its return on assets stood at -54.66% with a return of equity of -113.24%.

In Q2, VentriPoint Diagnostics Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a negative 84.2%.

VentriPoint Diagnostics Ltd’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-0.02 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into VentriPoint Diagnostics Ltd’s profitability.

VentriPoint Diagnostics Ltd stock is trading at a EV to sales ratio of 705.6483 and a EV to EBITDA ratio of -5.8498. Its price to sales ratio in the trailing 12-months stood at 897.0447.

VentriPoint Diagnostics Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$3.89 million
Total Liabilities
$1.17 million
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

VentriPoint Diagnostics Ltd ended 2023 with $3.89 million in total assets and $0 in total liabilities. Its intangible assets were valued at $3.89 million while shareholder equity stood at $2.39 million.

VentriPoint Diagnostics Ltd ended 2023 with $0 in deferred long-term liabilities, $1.17 million in other current liabilities, in common stock, $-51081550.00 in retained earnings and $0 in goodwill. Its cash balance stood at $3.31 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $82959.00.

VentriPoint Diagnostics Ltd’s total current assets stands at $3.61 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $13686.00 compared to accounts payable of $835173.00 and inventory worth $0.

In 2023, VentriPoint Diagnostics Ltd's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, VentriPoint Diagnostics Ltd paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

VentriPoint Diagnostics Ltd stock is currently trading at $0.17 per share. It touched a 52-week high of $0.255 and a 52-week low of $0.255. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.2 and 200-day moving average was $0.18 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 175% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About VentriPoint Diagnostics Ltd

The stock symbol (also called stock or share ticker) of VentriPoint Diagnostics Ltd is VPTDF

The IPO of VentriPoint Diagnostics Ltd took place on

Similar Industry Stocks (Medical Devices)

Last Price
Sunworks Inc (SUNW)
Gloster Ltd (GLOSTERLTD)
SJVN Limited (SJVN)

Most Active

Last Price
Amyris Inc (AMRS)
Humbl Inc (HMBL)

Top Gainers

Last Price
Latch Inc (LTCHW)

Top Losers

Last Price


Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.


18 Hook Avenue, Toronto, ON, Canada, M6P 1T4